Braberg, Hannes http://orcid.org/0000-0002-7070-2257
Echeverria, Ignacia http://orcid.org/0000-0003-4717-1467
Kaake, Robyn M. http://orcid.org/0000-0002-8341-3067
Sali, Andrej http://orcid.org/0000-0003-0435-6197
Krogan, Nevan J. http://orcid.org/0000-0003-4902-337X
Article History
Accepted: 25 November 2021
First Online: 10 January 2022
Competing interests
: The Krogan Laboratory has received research support from Vir Biotechnology and F. Hoffmann-La Roche. N.J.K. has consulting agreements with the Icahn School of Medicine at Mount Sinai, New York, Maze Therapeutics and Interline Therapeutics. N.J.K. is a shareholder in Tenaya Therapeutics, Maze Therapeutics and Interline Therapeutics, and a financially compensated Scientific Advisory Board Member for GEn1E Lifesciences, Inc. The other authors declare no competing interests.
Free to read: This content has been made available to all.